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Abstract 
Latent tuberculosis infection (LTBI), like active tuberculosis (TB) disease, disproportionately 
affects foreign-born persons living in the United States.  Without treatment, those diagnosed with 
LTBI risk going into active disease and potentially becoming infectious.  Determining any 
knowledge, attitudes, or social characteristics associated with a person’s decision to initiate LTBI 
treatment is significant for TB control.  A logic model based on the Theory of Reasoned Action 
functioned as a guide to understanding the antecedents related to LTBI treatment acceptance.  
Participants enrolled in the study at the time of LTBI treatment offer in a Southwest Ohio public 
health TB clinic.  An examination of knowledge, attitudinal, and demographic/social factors 
occurred among 31 foreign-born (FB) and 11 U.S.-born persons as well as LTBI accepters and 
decliners.  Of the 42 participants, 74 % were foreign-born and 81% accepted LTBI treatment 
(77% FB and 91% U.S.).  Foreign-born participants scored significantly lower on combined TB 
knowledge overall, but both FB and U.S.-born participants have a poor understanding of TB 
transmission.  Attitudes, subjective norms, and intentions towards LTBI treatment were similar 
between groups, although treatment decliners were less likely to believe they are infected with 
the TB germ and FB participants are more likely to believe they will miss taking some of their 
medications.  The study’s findings demonstrate a need for more detailed TB education to all 
LTBI treatment candidates in order to improve treatment acceptance, compliance, and 
completion. 
Keywords: attitude, foreign-born, intention, knowledge, latent tuberculosis infection 
(LTBI), social norms, Theory of Reasoned Action, tuberculosis (TB) 
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Assessment of Knowledge and Attitudes on Latent Tuberculosis Treatment Acceptance in a 
Southwest Ohio Public Health Clinic 
This study sought to determine if a person’s knowledge and attitudes about tuberculosis 
(TB) correspond to the likelihood of initiating latent tuberculosis infection (LTBI) treatment.  
The study also identified any knowledge, attitudinal, or social characteristic differences or 
similarities between U.S. and foreign-born persons.  Study results will assist clinicians with 
creating or choosing appropriate interventions to improve LTBI treatment initiation rates. 
Tuberculosis (TB), a bacteria that infected an estimated 9 million persons worldwide in 
2013 alone (World Health Organization [WHO], 2014), has plagued humankind for roughly ten 
millenniums; with the earliest evidence found in skeletal remains unearthed in the Eastern 
Mediterranean dated between 7236-6146 BCE (Hershkovitz et al., 2008).  According to the 
Centers for Disease Control and Prevention (CDC) (2014), tuberculosis rates in the United States 
(U.S.) continue to decline, but not to levels sought-after by the United States Department of 
Health and Human Services’ (2011) Healthy People 2020’s target of <1 case per 100,000 
population.  In fact, reported cases of TB continue to affect segments of the U.S. population 
disproportionately.  Homeless populations and foreign-born persons residing in the U.S. carry 
the highest burden of TB disease, as case rates illustrate they are 10 to 13 times more likely than 
U.S.-born individuals to be infected (CDC, 2014).  
These CDC statistics demonstrate a continued need for TB surveillance in the U.S., 
including screening for and treatment of latent tuberculosis infection (LTBI).  In 2011, the 
CDC’s Division of Tuberculosis’ Elimination (DTBE) developed new strategies to combat 
tuberculosis in the U.S.  These latest strategies arose from the current TB trends observed in the 
U.S., such as funding declines, case rate increases in foreign-born persons, and growing numbers 
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of antibiotic resistant strains (CDC, 2011).  The two highest priorities cited by the CDC’s DTBE 
group were that of early identification and treatment of TB infection and active disease as well as 
reducing TB in foreign-born persons traveling to or residing in the U.S. (CDC, 2011).  Timely 
diagnosis of LTBI and the acceptance and completion of appropriate preventative TB treatment 
play a significant role when attempting to reduce the U.S. TB rates closer to the suggested 
targets. 
TB experts estimate that latent tuberculosis infection affects one-third of the world’s 
population (WHO, 2014) or 2.3 billion people (World Bank, 2014) and over 11 million persons 
residing in the U.S., 63% of which are foreign-born (Bennett et al., 2008).  Without treatment, 5-
10% of these individuals will likely develop active tuberculosis disease, with the potential to be 
infectious (CDC, 2012) and those with additional risk factors such as HIV co-infection, current 
infliximab therapy, or age less than five years at time of infection have a lifetime risk upwards to 
20% (Hornsburgh, 2004).  Research has shown that treatment of LTBI can be effective at 
preventing future active TB disease.  Two key antibiotics recommended for LTBI treatment, 
isoniazid and rifampin, reduce the incidence of future, active disease if taken appropriately 
(Comstock, 1999; Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British 
Medical Research Council, 1992; Polesky et al., 1996).  However, due to the long treatment-
periods associated with anti-tuberculosis medications, anywhere from four to nine months, and 
various socio-cultural attitudes and beliefs, rates of LTBI treatment initiation and completion 
remain modest at best.  
A number of studies report uneven initiation rates of LTBI treatment dependent on 
healthcare setting.  For example, a hospital occupational health department revealed initiation 
rates as high as 98% (Shukla, Warren, Woeltje, Gruber, & Frasier, 2002) where other U.S. public 
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health clinics disclosed dismal rates ranging from anywhere from 44% (Goswami et al., 2012) to 
59% (Morano, Walton, Zelenev, Bruce, & Altice, 2013).  In a study that looked at the impact of 
LTBI treatment on active tuberculosis by Sterling et al. (2006), they ascertained that current 
LTBI treatment levels prevent approximately 21 to 58% of active TB cases; the difference 
associated with compliance and completion rates.  Because LTBI treatment is not mandatory for 
adults in the U.S., determining why an individual or specific population chooses to accept or 
refuse LTBI treatment is essential when attempting to increase LTBI treatment initiation and 
completion rates.   
Purpose Statement 
Ascertaining which socio-cultural elements are associated with an individual’s or specific 
population’s decision to initiate LTBI treatment is significant when attempting to develop 
interventions to combat tuberculosis disease in the U.S., especially in foreign-born populations.  
Treatment acceptance rates vary depending on the population studied; this study aims to identify 
any knowledge, attitude, or social characteristics that are associated with latent tuberculosis 
treatment acceptance or refusal. 
Literature Review 
 There are various reasons why individuals choose specific health behaviors and 
researchers interested in changing them must have an awareness of theories with this focus 
(Rimer, 2008).  Those theories considered expectancy-value theories focus on an individual’s 
expectations, beliefs, and overall value of a particular behavior’s outcomes and are important 
when studying the person’s intention to accept or refuse LTBI treatment.  For example, the 
Theory of Reasoned Action by Fishbein and Ajzen (1975) focuses on not only the individual’s 
predisposing risk factors such as knowledge, age, culture, or other defining demographics, but 
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also their personal attitudes and beliefs toward a behavior and that of their social network when 
deciding to carry out specific actions.  An intention to perform a particular behavior, such as 
LTBI treatment acceptance, correlates to positive attitudes and a supportive social network 
(Ajzen, 1991).   
Studies exploring factors that are associated with LTBI treatment initiation and 
completion exist and allow healthcare personnel to utilize the findings when creating 
interventions to improve LTBI acceptance and treatment rates.  A logic model (see Figure 1) that 
combines the Theory of Reasoned Action with antecedents or variables related to LTBI 
treatment initiation identified through the use of the Predisposing, Enabling, and Reinforcing 
(PER) Worksheet (Langlois & Hallam, 2008) demonstrates which variables found in the 
literature are associated with LTBI treatment initiation.  For this study, only variables found 
within the questionnaire obtained from Colson, Franks, Sondengam, Hirsch-Moverman, and El-
Sadr (2010) were studied. 
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Figure 1. Latent tuberculosis infection treatment initiation logic model based on the Theory of 
Reasoned Action.  Antecedents or variables analyzed in this study are highlighted in black. 
Source: Fishbein & Ajzen, 1975 
Various predisposing risk factors influence a person’s decision to accept or refuse LTBI 
treatment.  For example, being a close contact to an active TB case has a robust association with 
initiating LTBI treatment.  Motivation through fear or perceived threat, a well-known concept of 
the Health Belief Model, is a strong predictor for LTBI treatment initiation.  Simply being part of 
a TB contact investigation imparts a greater sense of apprehension for a future TB infection 
diagnosis.  Goswami et al. (2012) looked at the predictors of LTBI initiation and completion in a 
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persons and found that those persons part of a TB contact investigation were 2.5 times more 
likely to initiate LTBI treatment than those who completely unaware of their exposures.   
Demographics such as being foreign-born or undocumented are significantly associated 
with LTBI treatment initiation.  In a study of 357 Connecticut residents diagnosed with LTBI, 
being foreign-born increased the likelihood of initiating treatment by 25% and if undocumented, 
the odds grew to over two times that of legal residents and immigrants (Morano et al., 2013).  
Being of older age has a positive relationship with the initiation of LTBI treatment.  The older 
the person is at time of treatment offer, the more likely they are to accept.  Goswami et al. (2012) 
interviewed 496 persons offered LTBI treatment with a median age of 39.1 ± 12.3 years.  Of 
these 496 people, 130 initiated LTBI treatment.  The median age of those agreeing to treatment 
was 42.1 years, 7.7% higher compared to those who refused.  Having a non-employment reason 
for TB infection testing has a strong association with initiating LTBI treatment.  Of 402 
Connecticut citizens undergoing testing for TB infection, those persons presenting for testing 
unrelated to employment were 14% more likely to start LTBI treatment than those whose 
employer required the testing (Goswami et al., 2012). 
Accessibility to appropriate LTBI and TB information and the use of an interpreter have a 
strong relationship to accepting LTBI treatment.  A mixed methods study that focused on the 
socio-cultural factors in treatment and prevention of TB in Canadian Aborigines emphasized the 
low levels of TB knowledge in the Aboriginal community (Gibson, Cave, Doering, Ortiz, & 
Harms, 2005).  This study included the request of participant’s to improve the TB information 
supplied to the various communities by focusing on the format, setting, and available languages 
of the educational materials.  In a study by Butcher et al. (2013), utilization of an interpreter at 
time of LTBI treatment offer was associated with a 69% lower chance of having a high score 
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related to TB knowledge.  According to Butcher et al. (2013), every attempt should be made at 
utilizing interpreters with a strong understanding about the differences between active TB and 
latent infection as well as the use of medications used in treatment. 
Because LTBI has no symptoms, knowing the difference between active disease and 
infection has a direct relationship to the decision to accept treatment.  One quarter of Vietnamese 
participants in a qualitative study looking at LTBI treatment compliance indicated that because 
there are no symptoms associated with LTBI, taking the medication is not high priority.  When 
factoring in side effects and peer pressure, continuing LTBI treatment for long periods is a 
challenge (Ito, 1999).  In a recent study of tuberculosis patient’s knowledge about TB, Colson et 
al. (2014) found that having completed high school and advanced levels of education were 
highly associated with higher scores of TB knowledge which may impact a person’s decision to 
initiate and complete treatment.  The fear of getting sick with active tuberculosis if LTBI 
treatment is not initiated has a clear relationship to LTBI treatment initiation.  When looking at 
predictors of LTBI treatment initiation in the U.S., Goswami et al. (2012) found that 69% of 
persons initiating LTBI shared that they feared getting sick from active TB if they refused the 
preventive medications.   
Personal attitudes and beliefs towards TB and LTBI treatment play a role in an 
individual’s decision to accept treatment.  The belief that bacilli Calmette-Guerin (BCG) 
vaccination is protective is highly associated with lower LTBI treatment acceptance and 
completion rates.  BCG, a vaccine given to newborns in countries with high incidence of active 
tuberculosis disease, can generate a false sense of security for some with little knowledge of its 
waning effectiveness.  In a study of 404 healthcare workers offered LTBI treatment, Shukla et al. 
(2002) found that only half of persons who reported history of BCG vaccination actually initiated 
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LTBI treatment, as they believe they have life-long protection against TB.  In addition, half of 
those who initiated treatment were noncompliant with the treatment.  In another randomized 
controlled trial by Colson et al. (2010), one of the four-point Likert-scale study questions 
examines if the participant “felt protected from getting TB disease” (p. 862).  Foreign-born study 
participants were 17.9 % more likely than their U.S.-born counterparts were to answer “very 
likely” (2.64 vs. 2.23), with the assumption that the protection relates to their childhood BCG 
vaccination.   
Fear of side effects is inversely related to a person’s choice to initiate or complete LTBI 
treatment.  Because contraindications and occasionally serious side effects occur with LTBI 
treatment, some patients are resistant to taking it.  In Ito’s (1999) qualitative study of 24 
Vietnamese LTBI patients, eight of the ten non-compliant patients shared that they received 
pressure from family and friends to avoid LTBI treatment or not to take the medications after 
receiving them from the healthcare provider.  One of Ito’s (1999) study participant shared that 
even though the medications were free to the patients, “…side effects make them worry” (p. 
352). 
An individual knowing that they fall into a high-risk category for progressing from TB 
infection to active disease has a strong relationship to LTBI treatment initiation.  According to 
Goswami et al. (2012), those persons at high-risk for disease progression were 45% more likely 
to initiate LTBI treatment than those with moderate (35%) or low-risk (17%).  
The need for persons to obtain an LTBI treatment completion card has a direct 
relationship to LTBI treatment initiation as well as completion.  Studied by Ito (1999) in her 
qualitative study of Vietnamese refugees, half of the non-compliant participants returned to the 
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clinic to resume and complete treatment because obtaining the completion card opened doors to 
education and employment.   
Subjective norm is the “the perceived social pressure to perform or not to perform the 
behavior" in question (Ajzen, 1991, p. 188) and therefore if an individual’s peers are sympathetic 
and encouraging towards a behavior, the more likely a person is to perform it.  Some cultures 
look to others for strength as they battle tuberculosis, where others feel uncomfortable with the 
diagnosis and attempt to hide that they have the disease as well as its treatment.  In a 2010 study 
comparing U.S. and foreign-born LTBI patient’s knowledge, attitudes, and beliefs regarding 
tuberculosis, Colson et al. (2010) found that U.S.-born patients were significantly more likely 
(21.8%) to care more about what their family and friends thought about their treatment but less 
likely than foreign-born patients to feel shunned or embarrassed to have their TB status be 
known (10%).  A 2005 Canadian qualitative study found that social stigma, as it relates to 
tuberculosis, impacted the Aboriginal study patients four times that of the country’s immigrant 
participants as the majority revealed feelings of distrust from those around them because of their 
diagnosis (Gibson et al., 2005).  
Family support, committed relationships, and community encouragement are strongly 
associated with tuberculosis treatment acceptance.  Family support plays a vital role in the 
decision making process, even across cultures.  For some, without healthy family dynamics, 
agreeing to LTBI treatment and completing its long treatment course is seemingly impossible.  
Ito (1999) conducted a qualitative study that focused on the health culture of Vietnamese 
refugees who accepted LTBI treatment in California (n=24).  In her paper, Ito shared that when 
patients experienced side effects, family support made a difference in treatment continuance.  
Clinic personnel found it important to determine who in the household made the family decisions 
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– educating the family member along with the patient.  A second qualitative study utilized the 
Social Cognitive Theory to interpret beliefs in Midwestern migrants diagnosed with LTBI.  They 
too, found family support a powerful influence on medication compliance as spousal reminders 
and encouragement influenced compliance (Wyss & Alderman, 2006).  Another prospective 
study conducted in Connecticut, found that those persons in committed relationships at the time 
of LTBI treatment offering were 28% more likely to initiate the treatment versus those not in a 
committed relationship (Morano et al., 2013).  One cannot overlook the importance of 
community or social networks on LTBI treatment initiation and compliance.  Interactions 
between individuals and their peers are an important factor.  Eighty percent of Vietnamese non-
compliant LTBI patients studied by Ito (1999) reported either “direct or indirect pressure” from 
their peers to discontinue their preventative treatment.   
Methods 
Participants 
 All persons aged 18 through 80 years of age who met CDC guidelines for LTBI treatment 
between January 1 and December 31, 2014 at a southwest Ohio public health clinic were invited 
to participate in the study at time of LTBI treatment offer.  All participants provided written, 
informed consents. 
Materials and Procedure 
 The study’s questionnaire (Appendix A) was adapted from Colson et al. (2010) and 
focused on the participant’s knowledge, attitudes, and social demographics.  P. W. Colson 
granted permission for use of the questionnaire in this study (personal communication, July 15, 
2013).  Colson et al. (2010) designed the knowledge section to test a participant’s comprehension 
regarding TB transmission, testing, and treatment and utilized constructs from various health 
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behavioral theories such as the Theory of Reasoned Action, Health Belief Model, Social 
Learning Theory, and Social Action Model for the attitudinal questions.  A total knowledge score 
was also calculated for each participant by totaling correct knowledge responses.  Evaluation of 
attitudinal questions relied on a four-point Likert scale where a [1] corresponded to ‘Strongly 
disagree’ and a [4] indicated the participant ‘Strongly agreed.’  The social demographics section 
included gender, age, education, household income, employment status, language, region of 
birth, visa status, length of time in U.S., insurance status, and BCG vaccination and was adapted 
from Colson et al. (2014) (see Table 1 for independent and dependent variables used in the 
study).   
Table 1  
Independent and Dependent Variables used in Study 
Variable Operational Definition Range of Possible Scores/Coding 
Type of 
Variable 
Independent variables    
Contact characteristics 
Gender Participant’s gender Male = 0 Female = 1 
Categorical 
Age range Participant’s age range 
as present in de-
identified dataset 
 
18-24 = 0 
25-44 = 1 
≥ 45 = 2 
 
Categorical 
Education level Highest level of 
education achieved at 
time of LTBI offer 
8th grade or less = 0 
Some HS = 1 
HS graduate = 2 
Some college = 3 
College graduate = 4 
Post-graduate = 5 
Other = 6 
Don’t know = 9 
Refused = 10 
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Table 1  
Independent and Dependent Variables used in Study (continued) 
Variable Operational Definition Range of Possible Scores/Coding Variable Type 
Household income 




< $10,000  = 0 
$10 – 40,000  = 1 
>$40,000 = 2 
Don’t know = 9 
Refused = 10 
Missing data = 99 
 
Categorical 
English-speaking ability Participant’s ability to 
speak English 
Fluent English = 0 




World region of birth Which world region was 
the participant born 
Sub-Saharan Africa = 0 
Middle East/N Africa = 1 
South Asia = 2 
Latin Am/Caribbean = 3 
Mexico = 4 
E. Asia/Pacific Is = 5 
E. Europe/Central Asia = 6 
Western Europe = 7 
N. America/US & Canada = 8 
 
Categorical 
Visa status (at time of 
interview) 
Participant’s current 
U.S. Visa status 
Undocumented = 0 
Temporary = 1 
Permanent = 2 
No Visa required = 3 
Unknown/don’t know = 9 
Missing data = 99 
 
Categorical 
Length of time in the 
U.S. (in years) 
Amount of time 
participant has been in 
the U.S. 
0 – 1 = 0 
1 – 5 = 1 
>5 = 2 
Missing data = 99 
 
Categorical 




Yes = 1 
No = 0 
Unknown/don’t know = 9 
Missing data = 99 
 
Categorical 
Ever received BCG 
vaccination 
Did participant ever 
receive the BCG 
vaccine? 
Yes = 1 
No = 0 
Don’t know = 9 
Missing data = 99 
Categorical 
Interpreter Used Did participant require 
an interpreter based on 
English fluency? 
Yes = 1 
No = 0 
Categorical 
KNOWLEDGE AND ATTITUDES ON LTBI TREATMENT ACCEPTANCE  17 
Table 1  
Independent and Dependent Variables used in Study (continued) 
Variable Operational Definition Range of Possible Scores/Coding Variable Type 
Independent variables 
TB Knowledge 
11 TB knowledge 
questions 
Participant’s knowledge 
of TB and its symptoms 
True = 1 
False = 0 
Don’t know = 9 
Missing data = 99 
Categorical 
    
Independent variables    
TB Attitudes, Subjective Norm, and Intention 
14 attitude questions Participant’s feelings 
about TB and people 
with the disease 
Strongly disagree = 1 
Disagree somewhat = 2 
Agree somewhat = 3 
Strongly agree = 4 
Categorical 
 
Dependent variables    
LTBI Treatment    
LTBI treatment initiated Whether or not 
participant decided to 
initiate LTBI treatment 
Yes = 1 
No = 0 
Categorical 
    
Birthplace    
U.S.-Born Whether or not 
participant is U.S. born 
or not 
Yes = 1 
No = 0 
Categorical 
 
Health Clinic personnel administered the questionnaires in English and utilized 
interpreters if the participant had limited English proficiency.  The Wright State University 
Institutional Review Board (IRB) (see Appendix B) and the Public Health -Dayton and 
Montgomery County (PHDMC) Research and Review Panel (see Appendix C) approved the 
study.  
Data Analysis  
 Questionnaire data was entered into a Microsoft Excel database and analyzed utilizing 
IBM’s SPSS (IBM Corp., 2012) software.  Cross tabulations were used to compare differences in 
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demographics and TB knowledge between U.S.-born and foreign-born study participants and 
LTBI treatment acceptance.  Utilization of the two-tailed Chi-square or Fisher’s exact test at the 
<0.05 significance level revealed any differences among each of the categorical variables.  The t-
test was used when comparing the means of U.S.-born and foreign-born participants and LTBI 
treatment acceptance on continuous variables such as total knowledge scores and the attitudinal, 
subjective norm, and intention items.  
Results 
Participant Characteristics 
 Over half (57%, n = 24) of the participants were male, predominately foreign-born (74%, 
n = 31), and between the ages of 18 and 44 years (88%, n = 37).  Fifty-seven percent (n = 24) 
have lived in the U.S. less than five years and 38% (n = 16) required an interpreter at the clinic 
appointment.  Seventy one percent of study participants (n = 30) graduated from high school and 
50% (n = 21) said they were employed but made less than $40,000.00 per year (Table 2).   
Table 2 
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Age Range         
  18 – 24 years 13 30.95 12 38.71 1   9.09 7.05 0.03 
  25 – 44 years 24 57.14 14 45.16 10 90.91   
  ≥45 years 5 11.90 5 16.13 0   0.00   
Education Level         
  8th grade or less 5 11.90 5 16.13 0 0.00 6.41 0.38 
  Some HS 5 11.90 3 9.68 2 18.18   
  HS graduate 8 19.05 5 16.13 3 27.27   
  Some college 9 21.43 7 22.58 2 18.18   
  College graduate 12 28.57 9 29.03 3 27.27   
  Post-graduate 1 2.38 0 0.00 1 9.09   
  Don’t know 2 4.76 2 6.45 0 0.00   
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Income         
  <$10,000.00 16 38.10 13 41.94 3 27.27 9.39 0.02 
  $10 – 40,000.00 5 11.9 1 3.23 4 36.36   
  >$40,000.00 6 14.29 4 12.9 2 18.18   
  Refused/Don’t  
know/Missing data  
15 35.71 13 41.94 2 18.18   
Employed         
  Yes 21 50.00 13 41.94 8 72.73 3.08 0.21 
  No 14 33.33 12 38.71 2 18.18   
  Refused/Don’t 
know/Missing data  
7 16.67 6 19.35 1   9.09   
English language fluency         
  Fluent English 21 50.00 10 32.26 11 100  0.001 
  Not Fluent English 21 50.00 21 67.74 0 0.00   
VISA status         
  Temporary 13 30.95 13 41.94 0 0.00 17.46 0.001 
  Permanent 16 38.10 13 41.94 3 27.27   
  No VISA required 9 21.43 2 6.45 7 63.64   
  Unknown/Don’t 
know/Missing data 
4 9.52 3 9.68 1 9.09   
Time in US          
  0 – 1 years 10 23.81 10 32.26 0 0.00 21.92 0.001 
  1 – 5 years 14 33.33 14 45.16 0 0.00   
  >5  years 17 40.48 6 19.35 11 100   
  Missing  1 2.38 1 3.23 0 0.00   
Insurance status         
  Yes 27 64.29 21 67.74 6 54.55 0.95 0.62 
  No 13 30.95 9 29.03 4 36.36   
Unknown/don’t 
know/Missing data 
2 2.38 1 3.23 1 09.09   
Received BCG         
  Yes 12 28.57 12 38.71 0 0.00 6.36 0.04 
  No 9 21.43 5 16.13 4 36.36   
  Don’t know/Missing data 21 50.00 14 45.16 7 63.64   
Interpreter use         
  Yes 16 38.10 16 51.61 0 00.00 9.17 0.001 
  No 26 61.90 15 48.39 11 100.0   
LTBI treatment accepted         
  Yes 34 80.95 24 77.42 10 90.91 .96 0.33 
  No 8 19.05 7 22.58 1 09.09   
 
  
KNOWLEDGE AND ATTITUDES ON LTBI TREATMENT ACCEPTANCE  20 
Fifty percent (n = 21) of the participants were from the continent of Africa (26% Sub-Saharan 
Africa, n = 11; 24% Middle East/North Africa, n = 10 (see Table 3).   
Table 3 





(n = 42) 
 
% 
Sub-Saharan Africa 11 26.19 
Middle East/North Africa 10 23.81 
South Asia 4 9.52 
Latin America/Caribbean 1 2.38 
Mexico 1 2.38 
East Asia/Pacific Islands 2 4.76 
Eastern Europe/Central Asia 1 2.38 
Western Europe 1 2.38 
North America/US/Canada 11 26.19 
 
Thirty-four (81%) of the 42 persons in the study initiated LTBI treatment.  Table 4 
illustrates that of the 34 LTBI treatment accepters, just over half (59%, n = 20) were male, more 
likely to be foreign-born (71%, n = 24), spent less than five years in the U.S. (57%, n = 24), 
received BCG vaccination (29%, n = 12) and found to be between the ages of 25 and 44 years of 
age (62%, n = 21).  
Table 4 





























  Male 























Age Range         
  18 – 24 years 13 30.95 9 26.47 4 50.00 1.83 0.40 
  25 – 44 years 24 57.14 21 61.76 3 37.50   
  ≥45 years 5 11.90 4 11.76 1 12.50   
Education Level         
  8th grade or less 5 11.90 5 14.71 0 00.00 7.97 0.16 
  Some HS 5 11.90 5 14.71 0 00.00   
  HS graduate 8 19.05 4 11.76 4 50.00   
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  Some college 9 21.43 7 20.59 2 25.00   
  College graduate 12 28.57 10 29.41 2 25.00   
  Post-graduate 1 2.38 1 2.94 0 00.00   
  Don’t know 2 4.76 2 5.88 0 00.00   
Income         
  <$10,000.00 16 38.10 12 35.29 4 50.00 1.58 0.67 
  $10 – 40,000.00 5 11.9 5 14.71 0 00.00   
  >$40,000.00 6 14.29 5 14.71 1 12.50   
Refused/Don’t 
know/Missing data  
15 35.71 12 35.29 3 37.50   
Employed         
  Yes 21 50.00 16 47.06 5 62.50 2.01 0.37 
  No 14 33.33 13 38.24 1 12.50   
Refused/Don’t 
know/Missing data 
7 16.67 5 14.71 2 25.00   
English language 
fluency 
        
  Fluent English 21 50.00 16 47.06 5 62.50 0.62 0.43 
  Not Fluent English 21 50.00 18 52.94 3 37.50   
VISA status         
  Temporary 13 30.95 11 32.35 2 25.00 2.97 0.40 
  Permanent 16 38.10 11 32.35 5 62.50   
  No VISA required 9 21.43 8 23.53 1 12.00   
  Unknown/Don’t 
know/Missing data 
4 9.52 4 11.76 0 00.00   
Time in US         
  0 – 1 years 10 23.81 10 29.41 0 00.00 8.32 0.04 
  1 – 5 years 14 33.33 8 23.53 6 75.00   
  >5  years 17 40.48 15 44.12 2 25.00   
  Missing  1 2.38 1 2.94 0 0.00   
Insurance status         
  Yes 27 64.29 24 70.59 3 37.50 3.50 0.17 
  No 13 30.95 9 26.47 4 50.00   
Unknown/Don’t   
know/Missing data 
2 2.38 1 2.94 1 12.50   
Received BCG         
  Yes 12 28.57 9 26.47 3 37.50 6.82 0.03 
  No 9 21.43 5 14.71 4 50.00   
  Don’t know/Missing 
data 
21 50.00 20 58.82 1 12.50   
Interpreter use         
  Yes 16 38.10 16 47.06 0 00.00 7.41 0.01 
  No 26 61.9 18 52.94 8 100.0   
U.S. Born         
  Yes 11 19.05 10 90.91 1   9.09 0.96 0.33 
  No 31 80.95 24 77.42 7 22.58   
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US-born participants (n=11) were almost exclusively between the ages of 25–44 years 
(91%, n = 10 vs. 45%, n = 14, p = 0.03), had incomes >$10,000.00 (54%, n = 6 vs. 16%, n = 5, p 
= 0.02), spoke fluent English (100%, n = 11 vs. 32%, n = 10, p = 0.001), and less likely to have 
received BCG vaccination (0% vs. 39%, n = 12, p = 0.04) (Table 2).1  The majority of LTBI 
decliners were found to have spent just 1–5 years in the U.S. (75%, n = 6 vs. 23% n = 8, p = 
0.04), no recollection of the BCG vaccination (50%, n = 4 vs. 15%, n = 5, p = 0.03),1 and no 
need for interpreter (100%, n = 8 vs. 0%, p = 0.001) (see Table 4). 
TB Knowledge 
 Tables 5 and 6 display the participant’s TB knowledge based on birthplace and LTBI 
treatment acceptance.  Although participants answered the majority of TB knowledge questions 
correctly, TB transmission-related questions received the lowest “correct” scores regardless of 
the participant’s place of birth or decision to initiate treatment.  Both U.S. and foreign-born 
persons think TB can be transmitted by kissing where only 21% (n = 9, p = 0.04) correctly chose 
false and by sharing dishes and toothbrushes (31%, n = 13 answered false, p = 0.26) and just 
over half (52%, n = 22, p = 0.10) of participants knew that LTBI was not contagious.  Although 
not significant, foreign-born persons scored higher on the TB diagnosis and treatment questions.  
They understand a positive TB test does not mean a person has TB disease (71%, n = 22, vs. 
55% n = 6, p = 0.30 correctly answered false) and know that having TB does not mean 
deportation for undocumented persons (64%, n = 20 vs. 55% n = 6, p = 0.80).  Total mean 
knowledge scores were found to be significant between foreign and U.S.-born persons (M = 6.61 
vs. M = 8.0, p = 0.01), but not between LTBI treatment accepters and decliners (M =6.82 vs. M 
=7.63, p = 0.20).  
1 Twenty-one (21) respondent’s vaccination status unknown. 
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Table 5 



























TB Transmission Knowledge         
Person can get TB by:         
  Crowded conditions 36 85.71 26 83.87 10 90.91 0.57 0.33 
  Sharing dishes/toothbrushes+ 13 30.95 7 22.58 6 54.55 4.06 0.26 
  Kissing+ 9 21.43 5 16.13 4 36.36 6.56 0.04 
  Stranger more than family+ 26 61.90 16 51.61 10 90.91 5.36 0.07 
  LTBI is contagious+ 22 52.38 14 45.16 8 72.73 4.63 0.10 
  Person with HIV more likely to get 
TB 
35 83.33 26 83.87 9 81.82 2.24 0.33 
Diagnosis Knowledge         
  + Skin test means you have disease+ 28 66.67 22 70.97 6 54.55 3.65 0.30 
Treatment Knowledge         
  + TB test may mean need for 
medications 
33 78.57 22 70.97 11 100.0 4.06 0.13 
  Most TB can be cured with 
medications(s) 
35 83.33 24 77.42 11 100.0 2.98 0.23 
  LTBI treatment can take 1 month+ 32 76.19 25 80.65 7 63.64 3.36 0.19 
Undocumented persons with TB can 
be deported+ 
26 61.90 20 64.52 6 54.55 0.45 0.80 
 M SD M SD M SD t  
Mean Knowledge Score* 6.98 1.57 6.61 1.45 8 1.48 -2.71 0.01 
Note: + “False” is correct response 
*Out of possible 11 total points 
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Table 6 




































TB Transmission Knowledge         
Person can get TB by:         
  Crowded conditions 36 85.71 30 88.24 6 75.00 0.93 0.34 
  Sharing dishes/toothbrushes+ 13 30.95 12 35.29 1 12.50 1.99 0.37 
  Kissing+ 9 21.43 7 20.59 2 25.00 1.34 0.51 
  Stranger more than family+ 26 61.90 19 55.88   7 87.50 2.80 0.25 
  LTBI is contagious+ 22 52.38 19 55.88 3 37.5 3.58 0.17 
  Person with HIV more likely to get 
TB 
35 83.33 27 79.41 8 100.0 1.98 0.37 
Diagnosis Knowledge         
  + Skin test means you have disease+ 28 66.67 21 61.76 7 87.50 2.28 0.32 
Treatment Knowledge         
  + TB test may mean need for 
medications 
33 78.57 26 76.47 7 87.50 0.56 0.76 
  Most TB can be cured with 
medications(s) 
35 83.33 28 82.35 7 87.50 0.82 0.66 
  LTBI treatment can take 1 month+ 32 76.19 24 70.59 8 100.0 3.09 0.21 
Undocumented persons with TB can 
be   deported+ 
26 61.90 20 58.82 6 75.00 1.26 0.53 
 M SD M SD M SD T  
Mean Knowledge Score* 6.98 1.57 6.82 1.66 7.63 0.92 1.31 0.20 
Note. + “False” is correct response 
*Out of possible 11 total points 
TB Attitudes and Beliefs 
 Table 7 demonstrates how attitudes towards TB among all participants, regardless of 
birthplace, were similar.  Both foreign and U.S.-born persons agree that if they do the right thing, 
TB can be prevented (M = 2.44, SD = 1.00; p = 0.15) on a 4-point Likert scale, you can get TB 
no matter what you do (M = 2.65, SD = 1.00; p = 0.10), and BCG vaccination prevents TB 
disease (M = 2.73, SD = 0.99; p = 0.31).  Both groups were also likely to disagree with 
statements such as not trusting the doctor to give best care (M = 1.57, SD = 0.99; p = 0.25), 
going to appointments are more trouble than they are worth (M = 1.61, SD = 0.95; p = 0.32), and 
you know better when to stop TB meds than the doctor (M = 1.71, SD = 1.09; p = 0.56).  
However, a significant finding was uncovered when looking at TB attitudes between LTBI 
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treatment-acceptance groups (see Table 8).  Those persons choosing not to take treatment were 
less likely to believe they have the TB germ (M = 1.63, SD = 0.92 vs. M = 2.91, SD = 1.00; p = 
0.001). 
Table 7 




























Attitudes toward LTBI treatment         
  BCG prevents TB disease 2.73 0.99 2.85 1.03 2.40 0.84 1.03 0.31 
  No matter what, you can get TB germs 2.65 1.00 2.50 1.01 3.10 0.88 -1.68 0.10 
  You know better than doctor when to     
stop TB meds 
1.71 1.09 1.77 1.12 1.55 1.04 0.59 0.56 
  Going to appointments more trouble than 
worth 
   1.61 0.95 1.70 0.99 1.36 0.81 1.01 0.32 
  Don’t trust Dr. to give best care 1.57 0.99 1.68 1.08 1.27 0.65 1.17 0.25 
  If you do the right thing, TB prevented 2.44 1.00 2.42 1.03 2.50 0.97 1.47 0.15 
  You believe that you have TB germ 2.67 1.10 2.61 1.09 2.82 1.17 -0.53 0.60 
  Taking TB medicine is a hassle 2.02 1.05 2.13 1.06 1.73 1.01 1.10 0.28 
Subjective norm         
  You worry about passing TB to loved 
ones 
2.98 1.14 3.06 1.09 2.73 1.27 0.84 0.40 
You are embarrassed to tell people you 
have the TB germ 
2.33 1.16 2.29 1.24 2.45 0.93 -0.40 0.69 
You care about what family/friends think 
about TB treatment 
2.69 1.02 2.65 1.05 2.82 0.98 -0.48 0.64 
Intention          
  Taking your TB medicine is important 3.45 0.83 3.32 0.91 3.82 0.40 -1.74 0.09 
  As hard as you try, you will miss taking 
some TB medicine 
2.58 1.11 2.72 1.00 2.18 1.33 1.40 0.17 
  It will take something bad to keep you 
from taking your medicine 
2.64 1.10 2.39 1.05 3.36 0.92 -2.72 0.01 
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Table 8 
Tuberculosis Attitudes and Beliefs by LTBI Treatment Acceptance 





   
 Total  LTBI 
Tx 
    
 (N=42)  (n=34)     
Attitudes/Beliefs M SD M SD SD T-test p 
Attitudes toward LTBI treatment         
  BCG prevents TB disease 2.73 0.99 2.80 1.00 2.43 0.98 -0.89 0.38 
  No matter what, you can get TB germs 2.65 1.00 2.69 1.03 2.50 0.93 -0.47 0.64 
  You know better than doctor when to     
stop TB meds 
1.71 1.09 1.68 1.07 1.88 1.25 0.46 0.65 
  Going to appointments more trouble than 
worth 
1.61 0.95 1.52 0.87 2.00 1.20 1.31 0.20 
  Don’t trust Dr. to give best care 1.57 0.99 1.53 0.96 1.75 1.16 1.08 0.31 
  If you do the right thing, TB prevented 2.44 1.00 2.42 1.03 2.50 0.93 0.50 0.63 
  You believe that you have TB germ 2.67 1.10 2.91 1.00 1.63 0.92 -3.33 0.001 
  Taking TB medicine is a hassle 2.02 1.05 2.09 1.11 0.71 0.25 -0.82 0.42 
Subjective norm         
  You worry about passing TB to loved 
ones 
2.98 1.14 2.94 1.15 3.13 1.13 0.41 0.69 
You are embarrassed to tell people you 
have the TB germ 
2.33 1.16 2.41 1.21 2.00 0.93 -0.90 0.37 
You care about what family/friends think 
about TB treatment 
2.69 1.02 2.76 1.07 2.38 0.74 -0.97 0.34 
Intention          
  Taking your TB medicine is important 3.45 0.83 3.56 0.79 3.00 0.93 -1.75 0.09 
  As hard as you try, you know you will  
miss taking some TB medicine 
2.58 1.11 2.62 1.16 2.33 0.82 -0.58 0.57 
  It will take something bad to keep you 
from taking your medicine 
2.64 1.10 2.62 1.13 2.75 1.04 0.30 0.76 
         
 Subjective norms were similar, however not statistically significant across all study 
groups as found in Tables 7 and 8.  Foreign-born persons are more likely to worry about passing 
TB to love ones (M = 3.06, SD = 1.09 vs. M = 2.73, SD = 1.27; p = 0.40).  Those who started 
LTBI treatment were more likely to be embarrassed to tell people they have the germ (M = 2.41, 
SD = 1.21 vs. M = 2.00, SD = 0.93; p = 0.69) and care what family and friends think about their 
treatment (M = 2.76, SD = 1.07 vs. M = 2.38, SD = 0.74; p = 0.64).   
 Tables 7 and 8 reveal how intention between birthplace and LTBI treatment acceptance 
groups were also similar.  The majority of participants were likely to agree that taking TB 
medicine is important (M = 3.45, SD = 0.83; p = 0.09).  However, a statistically significant 
KNOWLEDGE AND ATTITUDES ON LTBI TREATMENT ACCEPTANCE  27 
difference exists between foreign and U.S.-born participants when deciding if it will take 
something bad to keep them from taking their medicine (M = 2.39, SD = 1.05 vs. M = 3.36, SD 
= 0.92; p = 0.01).   
Discussion 
 This study utilized a logic model based on Fishbein and Ajzen’s (1975) Theory of 
Reasoned Action to explore any associations between predisposing risk factors, attitudes, 
subjective norms, and intention antecedents of foreign- or U.S.-born persons and LTBI treatment 
accepters or decliners.  Although this study’s LTBI initiation rate was 81% (n = 34); well above 
the 44–59% rates published in other similar studies by (Goswami et al., 2008; Morano et al., 
2013), results reveal notable differences in knowledge levels, as well as attitudinal variations 
regarding beliefs they have the TB germ or likelihood of missing medication doses.  In order to 
ensure LTBI’s effective ness, strategies focusing on TB education at time of treatment offer is 
critical. 
 Predisposing risk factors varied among participants and influenced LTBI treatment 
initiation.  However, being foreign-born or employed, with or without insurance in this study 
was not associated with an increase in LTBI initiation rates as found by Morano et al. (2013).  In 
fact, almost 91% (n = 10/11) of the U.S. participants accepted treatment compared to 77% (n = 
24/31) of the foreign-born and employment was not associated with LTBI initiation as 62% (n = 
5) of decliners communicated being employed.  Age too, although significant between place of 
birth participants, did not yield a significant result between treatment acceptors and decliners as 
found by Goswami et al. (2012).  Unlike the study conducted by Colson et al. (2010), where 
there were no differences in total knowledge scores, knowledge scores in this study were 
significant between foreign- and U.S.-born persons.  Participants who were born in the U.S. had 
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statistically significant higher mean scores (M = 8, SD =1.48 vs. M = 6.61, SD = 1.45; p = 0.01).  
However, the knowledge scores were not associated with whether or not a person chose to 
initiate treatment.  Regardless of birthplace or decision to accept LTBI treatment or not, 
knowledge regarding TB transmission received the lowest amount of correct answers, 
demonstrating a need for further education in this area.  The study’s findings on interpreter use 
among LTBI treatment accepters and decliners was insightful as there was no interpreter use 
among decliners yet three of the eight were not fluent in English; an important risk factor 
supported by Butcher et al. (2013) and Gibson et al. (2005).   
Attitudes and beliefs toward TB and LTBI treatment, although similar between foreign- 
and U.S.-born participants, revealed noted significance between LTBI treatment accepters and 
decliners, where decliners are less likely to agree that they have the TB germ.  This idea mirrors 
the Ito (1999) qualitative study finding where the majority of participants, because they are 
without symptoms, do not believe they are ill and in turn refuse treatment.  Although not found 
to be statistically significant, foreign-born persons were more likely to feel BCG vaccination 
prevents disease and believe that taking TB medications is a hassle.  These types of attitudes are 
worrisome, especially as rates of active TB disease in our country continue to affect our foreign-
born population disproportionately (CDC, 2014). 
 Attitudinal questions with a focus on subjective norms resulted in no statistically 
significant findings.  However, foreign-born participants and treatment decliners were more 
likely than their U.S. participants were to worry about passing TB to loved ones but less likely to 
be embarrassed to tell people they have the TB germ or to be concerned about what family and 
friends think about their treatment.   
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 Intention related to LTBI treatment initiation in this study uncovered a statistically 
significant difference between U.S.- and foreign-born participants where the U.S. participants 
believe that it will take something bad to keep them from taking their medications.  While not 
statistically significant, LTBI treatment accepters were more likely to believe in the importance 
of taking their medications but also assumed they would miss some doses.  These beliefs towards 
medication compliance have the potential to influence the treatment’s overall effectiveness and 
overall, result in resistant strains and greater numbers of active TB disease. 
 This study has several limitations.  Due to time constraints, the sample size, although 
large enough to provide statistically significant results, was smaller than originally anticipated 
and because the sample was taken from clinic patients only, is not representative of the 
population as a whole.  The questionnaire obtained from P. W. Colson in 2013, chosen based on 
its previous use and therefore validity, contained many of the LTBI initiation logic model’s 
antecedents or variables, but not all (Figure 1).  Study decliners also adversely affected the total 
sample size as 13 clinic patients refused to participate.  Because almost 40% (n = 16) of study 
participants required interpreters, accuracy in the translation of TB concepts may have affected 
responses. 
Conclusion 
 The most significant findings in this study include the lack of knowledge regarding TB 
transmission among all individuals offered LTBI treatment, low total knowledge scores of 
foreign-born participants, and the treatment decliner’s disbelief that they have the TB germ.  
These particular study outcomes associated with knowledge and attitude towards LTBI treatment 
point to the need for additional education about latent TB infection at time of treatment offer and 
possibly the need for specialized training of interpreters about TB transmission and treatment.  
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The importance of interpreter use for persons with limited English fluency cannot be 
underestimated.  In retrospect, this study did not obtain baseline knowledge levels on participants 
prior to treatment offer, which may be helpful in future studies.   
Subjective norms surrounding LTBI treatment did not offer any significant results, but 
did demonstrate that U.S.-born persons are more likely to be embarrassed  to tell people they 
have LTBI and care what family and friends think about treatment, but less likely to worry about 
passing TB to loved ones – an outcome that may be associated with knowledge levels.   
Answers to intention questions related to starting and continuing LTBI treatment 
demonstrate that foreign-born persons believe they will miss taking their medication.  This lack 
of intention may hamper successful treatment rates and in turn may increase the foreign-born 
person’s chances of going into active tuberculosis disease. 
 Most study results point to the need for an increase in TB education, but finding the right 
avenue may prove to be difficult.  In order to improve LTBI treatment uptake and compliance, 
providing all clinic patients with culturally specific education and accurate translation is 
imperative.  Unfortunately, clinic education alone cannot change attitudes and beliefs that have 
taken years and decades to develop.  As recommended by Ito (1999), practitioners must not only 
consider a patient’s health culture when creating medical messages designed to improve uptake 
and treatment completion but also develop partnerships with community agencies that can assist 
with the development of educational materials and ongoing outreach.  The findings of this study 
could assist TB clinicians with developing culturally enriched education and expanding 
community partnerships with various cultural groups in an attempt to promote the acceptance 
and adherence of latent tuberculosis treatment. 
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Appendix A - Study Questionnaire 
 
  
Questionnaire on TB Knowledge ID# ___________________
Interpreter utilized: Yes   No   LTBI treatment accepted:  Yes   No 
This questionnaire is designed to find out how much you know about tuberculosis also called TB.  Please tell 
me if you think the following statements are true or false.  If you are not sure, choose the one you think is
most likely. TRUE FALSE DK
  1. A person can get TB by living in crowded conditions such as a shelter or jail. 1 0 9
  2. A person can get TB by sharing dishes, bottles, or a toothbrush with someone 1 0 9
      who has TB.
  3. A person can get TB through kissing. 1 0 9
  4. You are more likely to get TB from a stranger than from a family member. 1 0 9
  5. A positive TB skin test always means that a person has TB disease. 1 0 9
  6. If someone has TB germs "sleeping" in their body, they can give TB to 1 0 9
      other people.
  7. People with positive TB skin tests may need to take TB medicine. 1 0 9
  8. Most cases of TB disease can be cured by taking medicines. 1 0 9
  9. People who have HIV are more likely to get TB disease. 1 0 9
10. Treatment of "sleeping" TB germs can be completed in as little as 1 month. 1 0 9
11. An undocumented person who goes for TB care could be deported. 1 0 9
Which of the following symptoms can be found in people who are sick with TB?
*Interviewer's note: the subject should be clear that the questions are about symptoms of the "disease"
NOT "side-effects" of treatment. Yes No DK
12. Losing weight 1 0 9
13. Swollen feet 1 0 9
14. Coughing 1 0 9
15. Vomiting 1 0 9
16. Coughing up blood 1 0 9
Questionnaire on TB Attitudes
Now I would like to ask you a few questions about how you feel about TB and people with TB.
*Interviwer should read aloud the four choices on the scale: 1 = strongly disagree, 2 = disagree somewhat,
3 = agree somewhat, 4 = strongly agree 1 2 3 4
17. The BCG vaccine will prevent you from getting TB disease.
18. No matter what you do, you could still get the TB germ.
19. Taking your TB medicine is important.
20. You know better than the doctor when it's time to stop taking your medicine.
21. Going to clinic appointments is more trouble than it's worth.
22. You do not trust your doctor to give you the best care.
23. If you do the right thing, you can avoid getting TB disease.
24. You worry about passing the TB germ to the people you live with.
25. You are embarrassed to tell people you have the TB germ.
26. You believe that you have the TB germ.
27. You care about what your family and friends thing of your TB treatment.
28. As hard as you try, you know you're going to miss taking some of your medicine.
29. Taking your TB medicine is a hassle.
30. It's going to take something really bad to keep you from taking your medicines.
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  1. Gender   7. World region of birth
      Male       Sub-Saharan Africa
      Female       Middle East/North Africa
  2. Age (years)       South Asia
      18 - 24       Latin America/Caribbean
      25 - 44       Mexico
      45 - 64       East Asia/Pacific Islands
      65+       East Europe/Central Asia
  3. Education       Western Europe
      8th grade or less (includes no school)       North America/U.S. & Canada
      Some highschool/secondary school   8. Visa status at time of interview
      Highschool/secondary school graduate       Undocumented
      Some college/university       Temporary
      College/university graduate       Permanent
      Post-graduate       No Visa required
      Other       Unknown
      Don't know   9. Length of time in the US (years)
      Refused to answer       0 - 1
  4. Household income (prior to diagnosis)       1 - 2
      < $10,000       2 - 3
      $20,000 - 29,999       3 - 4
      $30,000 - 39,999       4 - 5
      $40,000 - 49,999       5 - 10
      $50,000 - 59,999       > 10
      $60,000 - 69,999       Missing data
      > $70,000 10. Insurance status when diagnosed
      Don't know       Yes
      Refused to answer       No   
  5. Employed at time of diagnosis       Unknown
      Yes 11. Ever received BCG vaccination
      No       Yes
      Don't know       No
      Refused to answer       Don't know
  6. English-speaking ability
      English speaker
      Speaks some English
      Speaks no English
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Appendix B - IRB Approval and Extension 
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Appendix B (continued) 
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Appendix C - 
Public Health - Dayton & Montgomery County Research Project Acceptance 
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Appendix D – Public Health Competencies Used in CE 
Tier 1 Core Public Health Competencies  
Domain #1: Analytic/Assessment Skills 
Describes factors affecting the health of a community (e.g., equity, income, education, environment) 
Identifies quantitative and qualitative data and information (e.g., vital statistics, electronic health records, 
transportation patterns, unemployment rates, community input, health equity impact assessments) that 
can be used for assessing the health of a community 
Applies ethical principles in accessing, collecting, analyzing, using, maintaining, and disseminating data 
and information 
Uses information technology in accessing, collecting, analyzing, using, maintaining, and disseminating 
data and information 
Selects valid and reliable data 
Selects comparable data (e.g., data being age-adjusted to the same year, data variables across datasets 
having similar definitions) 
Identifies gaps in data 
Collects valid and reliable quantitative and qualitative data 
Describes public health applications of quantitative and qualitative data 
Uses quantitative and qualitative data 
Describes assets and resources that can be used for improving the health of a community (e.g., Boys & 
Girls Clubs, public libraries, hospitals, faith-based organizations, academic institutions, federal grants, 
fellowship programs) 
Contributes to assessments of community health status and factors influencing health in a community 
(e.g., quality, availability, accessibility, and use of health services; access to affordable housing) 
Describes how evidence (e.g., data, findings reported in peer-reviewed literature) is used in decision 
making 
Domain #3: Communication Skills 
Identifies the literacy of populations served (e.g., ability to obtain, interpret, and use health and other 
information; social media literacy) 
Communicates in writing and orally with linguistic and cultural proficiency (e.g., using age-appropriate 
materials, incorporating images) 
Domain #4: Cultural Competency Skills 
Describes the concept of diversity as it applies to individuals and populations (e.g., language, culture, 
values, socioeconomic status, geography, education, race, gender, age, ethnicity, sexual orientation, 
profession, religious affiliation, mental and physical abilities, historical experiences) 
Describes the diversity of individuals and populations in a community 
Describes the ways diversity may influence policies, programs, services, and the health of a community 
Domain #5: Community Dimensions of Practice Skills 
Suggests relationships that may be needed to improve health in a community 
Domain #6:Public Health Sciences Skills 
Identifies prominent events in the history of public health (e.g., smallpox eradication, development of 
vaccinations, infectious disease control, safe drinking water, emphasis on hygiene and hand washing, 
access to health care for people with disabilities) 
Describes how public health sciences (e.g., biostatistics, epidemiology, environmental health sciences, 
health services administration, social and behavioral sciences, and public health informatics) are used in 
the delivery of the 10 Essential Public Health Services 
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Domain #6:Public Health Sciences Skills (cont’d) 
Retrieves evidence (e.g., research findings, case reports, community surveys) from print and electronic 
sources (e.g., PubMed, Journal of Public Health Management and Practice, Morbidity and Mortality 
Weekly Report, The World Health Report) to support decision making 
Recognizes limitations of evidence (e.g., validity, reliability, sample size, bias, generalizability) 
Describes evidence used in developing, implementing, evaluating, and improving policies, programs, and 
services 
Describes the laws, regulations, policies, and procedures for the ethical conduct of research (e.g., patient 
confidentiality, protection of human subjects, Americans with Disabilities Act) 
Contributes to the public health evidence base (e.g., participating in Public Health Practice-Based 
Research Networks, community-based participatory research, and academic health departments; 
authoring articles; making data available to researchers) 
Domain #7: Financial Planning and Management Skills 
Adheres to organizational policies and procedures 
Domain #8: Leadership and Systems Thinking Skills 
Incorporates ethical standards of practice (e.g., Public Health Code of Ethics) into all interactions with 
individuals, organizations, and communities 
Describes public health as part of a larger inter-related system of organizations that influence the health 
of populations at local, national, and global levels 
Describes the ways public health, health care, and other organizations can work together or individually 
to impact the health of a community 
Contributes to development of a vision for a healthy community (e.g., emphasis on prevention, health 
equity for all, excellence and innovation) 
 
Concentration Specific Competencies  
Global Health: 
Identify strategies that strengthen community capabilities for overcoming barriers to health and well-being  
Exhibit interpersonal skills that demonstrate willingness to collaborate, trust building abilities, and respect for 
other perspectives 
Identify and respond with integrity and professionalism to ethical issues in diverse economic, political, and cultural 
contexts 
Conduct evaluation and research related to global health 
 
